Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis
出版年份 2019 全文链接
标题
Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 49, Issue 6, Pages 769-778
出版商
Wiley
发表日期
2019-01-28
DOI
10.1111/apt.15146
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
- (2018) R. Zenouzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis
- (2018) Ahmad Hassan Ali et al. HEPATOLOGY
- Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis
- (2018) Andreas Wannhoff et al. Clinics and Research in Hepatology and Gastroenterology
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
- (2016) B. Njei et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis
- (2016) Andreas Wannhoff et al. DIGESTIVE DISEASES AND SCIENCES
- Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection
- (2016) Thomas G. Bird et al. PLoS One
- ACG Clinical Guideline: Primary Sclerosing Cholangitis
- (2015) Keith D Lindor et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biological variations of seven tumor markers
- (2015) Zhihong Qi et al. CLINICA CHIMICA ACTA
- Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis
- (2015) Andreas Wannhoff et al. Clinical Gastroenterology and Hepatology
- A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis
- (2015) Andreas Wannhoff et al. United European Gastroenterology Journal
- Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC - authors' reply
- (2014) C. Rupp et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
- (2014) C. Rupp et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection
- (2014) Darragh P. O'Brien et al. CLINICAL CANCER RESEARCH
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis
- (2013) Andreas Wannhoff et al. JOURNAL OF HEPATOLOGY
- Primary Sclerosing Cholangitis: New Approaches to Diagnosis, Surveillance and Treatment
- (2012) Michael Trauner et al. DIGESTIVE DISEASES
- Elevation of CA 125 and CA 19-9 in patients with end-stage liver disease
- (2012) Ashish Singhal et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Cancer surveillance in patients with primary sclerosing cholangitis
- (2011) Nataliya Razumilava et al. HEPATOLOGY
- Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment
- (2010) Daniel N. Gotthardt et al. GASTROINTESTINAL ENDOSCOPY
- Diagnosis and management of primary sclerosing cholangitis
- (2009) Roger Chapman et al. HEPATOLOGY
- Significance of Serum Tumor Markers Carcinoembryonic Antigen, CA 19-9, CA 125, and CA 15-3 in Pre-Orthotopic Liver Transplantation Evaluation
- (2009) A. Pissaia et al. TRANSPLANTATION PROCEEDINGS
- Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis
- (2008) Phunchai Charatcharoenwitthaya et al. HEPATOLOGY
- Gallbladder disease in patients with primary sclerosing cholangitis
- (2008) Karouk Said et al. JOURNAL OF HEPATOLOGY
- High lifetime risk of cancer in primary sclerosing cholangitis
- (2008) Marian M.H. Claessen et al. JOURNAL OF HEPATOLOGY
- Biological variation and reference change values of CA 19‐9, CEA, AFP in serum of healthy individuals
- (2008) G. Erden et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started